NCT04789486View on ClinicalTrials.gov

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

April 10, 2026

Study Completion Date

September 10, 2027

Conditions
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic CancerDuctal Adenocarcinoma of the Pancreas
Interventions
DRUG

AGuIX

Injected gadolinium-based nanoparticles

RADIATION

Radiotherapy

Stereotactic magnetic resonance-guided adaptive radiation therapy

Trial Locations (2)

02115

RECRUITING

Brigham and Women's Hospital, Boston

RECRUITING

Dana Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

NH TherAguix SAS
All Listed Sponsors
collaborator

NH TherAguix SAS

OTHER

lead

Dana-Farber Cancer Institute

OTHER